Young streak off a low base: a short run of consecutive-period improvement has just started, after a stretch that gave i
The model's full reasoning — Q4 2022 call → NOThe question asks whether management conveys that the business has put together a short, still-young run of consecutive periods of real improvement in a part of the business that had been unimpressive, with causes attached to the company and still in force. Let me examine the transcript for evidence of: 1. A prior stretch that was unimpressive, and a run that is still young 2. Improvement that is sequential and cumulative in management's own framing 3. Cause belonging to the company and still running Looking at the transcript: - Chad Robins: "2022 was a year of key decisions and achievements" - mentions restructuring, strategic goals, long-range financial plan, strengthened cash position. - "In MRD, clonoSEQ clinical volumes grew 51% versus fiscal year 2021" - this is year-over-year, not sequential. - "We finished the year with a strong fourth quarter of 55.2 million in total revenue representing a significant growth of 46% versus prior year." - "Fourth quarter volume grew 9% from third quarter to 10,526 tests delivered." - This is sequential quarter-over-quarter growth. - "Ordering healthcare providers and ordering accounts experienced significant growth of 56% and 47%, respectively, versus prior year, and unique patients tested grew 63%." - "Our revenue from MRD pharma partnerships... Quarterly revenue excluding regulatory milestones from these partnerships grew 52% versus prior year and 41% versus prior quarter." - This is sequential. - "We are off to a great start this year with clinical clonoSEQ orders at a record high for us in the past month." Now, is there a prior stretch that was unimpressive? The transcript doesn't really describe a prior weak period. It describes 2022 as a year of key decisions and achievements. The company restructured, set goals, and executed. There's no description of a prior weak, flat, declining, or stalled period. The question asks about a "part of the business that, until recently, had been giving investors little reason to expect it." The transcript doesn't really establish that. It talks about growth throughout. For sequential improvement: The fourth quarter volume grew 9% from third quarter. MRD pharma partnerships grew 41% versus prior quarter. But is there a string of consecutive periods? The transcript mentions one quarter-over-quarter improvement (Q4 vs Q3).
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| OLPX | Olaplex Holdings, Inc. | Q4 2023 | 2024-02-29 | D |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| BMBL | Bumble Inc. | Q3 2023 | 2023-11-07 | F |
| ALL | The Allstate Corporation | Q3 2023 | 2023-11-02 | C+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LEG | Leggett & Platt, Incorporated | Q3 2021 | 2021-11-02 | C |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
WRBY · Q1 2024 → YESThe question is about whether management conveys a short, still-young run of consecutive periods of real improvement in a part of the business that was previously unimpressive, caused by company-speci...
ASB · Q1 2024 → YESThe question is about whether management conveys a short, still-young run of consecutive periods of real improvement in a part of the business that was previously unimpressive, caused by company-speci...
KOPN · Q4 2023 → YESThe question is about whether management conveys a short, still-young run of consecutive periods of real improvement in a part of the business that was previously unimpressive, caused by company-speci...